Publication | Closed Access
Refold and Characterization of Recombinant Tissue Factor Pathway Inhibitor Expressed in Escherichia coli
52
Citations
0
References
1994
Year
E. ColiImmunologyMolecular BiologyEscherichia ColiE. Coli TfpiAntigen ProcessingInflammationProtein ExpressionProteomicsVirulence FactorMolecular MicrobiologyGene ExpressionCell BiologyProtein BiosynthesisNatural SciencesBiotechnologyProtein EngineeringMicrobiologyMedicineActive TfpiExtracellular Matrix
Human tissue factor pathway inhibitor (TFPI) was expressed in E. coli as a non-glycosylated protein with an additional alanine attached to the aminoterminus of the wild type molecule. High-level expression was obtained with pMON6875, a plasmid containing a tac promoter, Gene 10 leader from bacteriophage T7, methionine-alanine-TFPI coding sequence, and the p22 transcriptional terminator. In this system, TFPI accounted for about 5-10% of the total cell protein. The inclusion bodies containing. TFPI were sulfitolyzed, purified by anion-exchange chromatography, refolded through a disulfide interchange reaction, and further fractionated by Mono S cation exchange chromatography. The Mono S resin resolved a peak of highly active TFPI from relatively inactive and possibly misfolded molecules. The E. coli TFPI was shown to be about two-fold more active, on a molar basis, than full-length human SK hepatoma TFPI in a tissue factor-induced clotting assay in human plasma.